Document ID: EPA-HQ-OPP-2015-0291-0011
Agency: epa
Document Type: Supporting & Related Material
Title: 
Posted Date: 2015-06-24T04:00Z

Meeting Summary
         EPA Meeting with "Reach the Decision Makers" on Mancozeb
                                 May 29, 2014

Attendees
      USEPA Office of Pesticide Programs  
      Pesticide Re-evaluation Division: Rick Keigwin, Michael Goodis, Patricia Parrott, Tracy Perry, Richard Dumas 
      Health Effect Division:  Dana Vogel, Jess Rowland, Elizabeth Mendez, Michael Metzger, David Miller, Shanna Recore, Elizabeth Evans, Carol Christensen, Jeff Evans, Katelynn King
      Registration Division:  Cynthia Giles-Parker, Hope Johnson
      Field and External Affairs Division:  Kevin Keaney, Ashley Nelsen
      Office of General Counsel: Michelle Knorr (for FIFRA-related questions) 
      
      Reach the Decision Makers (REACH) Team  
      Jennifer Runkle, Postdoctoral Fellow, Emory University
      Joan Flocks, Director, Social Policy Division, Levin College of Law, University of Florida Anne Lang Dunlop, Associate Professor, Emory University
      Jeannie Economos, Pesticide Safety and Environmental Health Project Coordinator, Farmworker Association of Florida

Meeting Summary
   Representatives of the EPA Office of Pesticide Programs' Pesticide Re-evaluation Division, Health Effect Division, Registration Division, and Field and External Affairs Division met with a REACH team to discuss mancozeb.  The team presented their concerns regarding occupational exposure to mancozeb and potential developmental and reproductive effects.  This concern is based on the team's systematic review of mancozeb literature, which it will formally submit to the Agency for consideration in the registration review of mancozeb.  The public portion of the mancozeb registration review is scheduled to begin in June 2015, with the posting of the preliminary work plan and supporting documents for comment.
         
   The Agency noted that it would review the REACH team's findings during registration review and that it would add their policy brief/summary of scientific findings to the mancozeb registration review public docket.